Shirley Tilghman

Shirley Tilghman
Name	Shirley Tilghman
Birth date	November 17, 1946
Birth place	Toronto, Ontario, Canada
Nationality	Canadian, American
Fields	Molecular biology, Genetics, Developmental biology
Institutions	Princeton University, National Institutes of Health, Fox Chase Cancer Center, University of Toronto
Alma mater	Queen's University at Kingston, University of Toronto, Harvard University
Doctoral advisor	David Hogness
Known for	Mammalian embryonic development, Genomic imprinting, H19, X-inactivation

Shirley Tilghman is a molecular biologist and academic leader noted for work on mammalian gene expression and for serving as president of Princeton University. She has contributed to research on genomic imprinting, embryonic stem cells, and transcriptional regulation while also shaping science policy through advisory roles and public advocacy. Her career bridges laboratory science, university leadership, and national science policy.

Early life and education

Born in Toronto, Ontario, Tilghman attended Kingston schools before earning a Bachelor of Science from Queen's University at Kingston and a Ph.D. in biochemistry from the University of Toronto. She trained as a postdoctoral fellow at Harvard University in the laboratory of David Hogness at the Department of Molecular and Cellular Biology, working on regulatory elements in development and engaging with the research community that included scientists from Cold Spring Harbor Laboratory, Massachusetts Institute of Technology, and Harvard Medical School. Her early mentors and collaborators included researchers associated with Society for Developmental Biology, Genetics Society of America, and laboratories connected to the National Institutes of Health.

Research and scientific contributions

Tilghman's laboratory advanced understanding of mammalian development by investigating transcriptional regulation and imprinting at loci such as H19 and studies of X chromosome dynamics linked to X-chromosome inactivation research pioneered by groups at University of Cambridge and University of Oxford. Her work intersected with studies on embryonic stem cell pluripotency developed at University of Wisconsin–Madison and later by teams at Yale University and Stanford University. She contributed to mapping gene expression programs tied to developmental regulators studied alongside efforts at National Human Genome Research Institute and consortia like the Human Genome Project. Collaborations and intellectual exchanges with scientists from Cold Spring Harbor Laboratory, California Institute of Technology, Salk Institute, and Broad Institute influenced methods for investigating chromatin structure, enhancer function, and methylation studied at institutes such as Max Planck Society. Her publications integrated insights from researchers affiliated with Howard Hughes Medical Institute, National Academy of Sciences (United States), and international laboratories at ETH Zurich and Institut Pasteur.

Academic career and leadership

Tilghman held faculty appointments and leadership roles at institutions including Fox Chase Cancer Center and the University of Pennsylvania system before establishing a research program at Princeton University where she became a professor in the Department of Molecular Biology and later chaired departmental and university-level committees. She mentored students and postdoctoral fellows who subsequently joined faculties at Harvard Medical School, Yale School of Medicine, Columbia University, University of California, San Francisco, and Johns Hopkins University. Tilghman participated in governance bodies including the Howard Hughes Medical Institute, the Gordon and Betty Moore Foundation, and advisory panels for the National Science Foundation and the National Institutes of Health. Her administrative collaborations involved leaders from Harvard University, Yale University, Stanford University, and the University of Chicago.

Presidency of Princeton University

As president of Princeton University Tilghman led initiatives on undergraduate research, graduate training, and faculty recruitment that interacted with peer institutions such as Yale University, Harvard University, Columbia University, and University of Pennsylvania. She guided strategic planning in partnership with trustees and deans connected to organizations like the Association of American Universities, Ivy League, and the American Council on Education. Tilghman oversaw fundraising campaigns engaging donors linked to the Carnegie Corporation of New York, the Andrew W. Mellon Foundation, and corporate partners. During her tenure she addressed campus issues in dialogue with leaders from Syracuse University, Cornell University, and municipal officials from Princeton, New Jersey. She also worked with peer presidents from Duke University and Northwestern University on shared higher education priorities.

Public service, policy, and advocacy

Tilghman served on national advisory bodies including the President's Council of Advisors on Science and Technology and provided testimony before committees of the United States Congress and panels convened by the National Academies of Sciences, Engineering, and Medicine. She advocated for policies supporting biomedical research funding at the National Institutes of Health and for immigration policies affecting international scientists in coordination with groups like the American Association for the Advancement of Science and the Association of American Universities. Tilghman engaged in public discourse alongside figures from Bill & Melinda Gates Foundation, Alfred P. Sloan Foundation, and the Rockefeller Foundation on science workforce development and on diversity initiatives similar to programs at Smith College and Spelman College. She also contributed to dialogues on research integrity with peers from European Molecular Biology Organization and national organizations such as the Wellcome Trust.

Awards, honors, and recognitions

Tilghman's honors include election to the National Academy of Sciences (United States), the American Academy of Arts and Sciences, and membership in the Institute of Medicine (now the National Academy of Medicine). She received awards from entities including the American Philosophical Society, the Gairdner Foundation, and accolades associated with the Royal Society of Canada and the Royal Society. Additional recognitions came from university associations such as Ivy League honors and honorary degrees from institutions like Harvard University, Yale University, Columbia University, Brown University, and McGill University. Tilghman has been listed among influential leaders in science alongside figures from Francis Crick-era narratives and contemporary awardees connected to the Nobel Prize community.

Category:1946 births Category:Living people Category:Canadian scientists Category:American university and college presidents